[Webinar] TSCA Tuesdays: Health and Safety Data

November 2nd, 12:00 pm - 1:00 pm EDT
Wiley Rein LLP
November 2nd, 2021
12:00 PM - 1:00 PM EDT

Martha Marrapese will break down the Toxic Substances Control Act (TSCA) section 8 reporting rules on existing chemicals and the U.S. Environmental Protection Agency’s (EPA’s) planned TSCA Data Reporting (TDR) rulemaking.

Save the Dates for Upcoming Webinars

December 7, 2021
Risk Management Strategies:
Erik Baptist and Charlotte Bertrand will take a deep dive into EPA’s risk evaluations and strategic approaches for the risk management phase of TSCA.
12:00 p.m. - 1:00 p.m. EST

January 4, 2022
2022 Forecasting: Erik Baptist will provide a 2022 forecast for transformative developments that will set the tone for TSCA for the new year and years to come.
12:00 p.m. - 1:00 p.m. EST

February 1, 2022
Innovating Under TSCA: Martha Marrapese will examine the ability of companies to commercialize emerging chemistries necessary to support the Biden Administration climate and energy agendas under TSCA’s new chemicals program.
12:00 p.m. - 1:00 p.m. EST

About the Series

EPA’s implementation of TSCA continues to have many moving parts. We are delighted to announce an exciting TSCA webinar series starting this fall to help regulatory professionals and legal counsel stay informed.

Wiley’s speakers will cover the map and guide listeners on where TSCA is heading. Special guests from industry and government are planned to contribute to our informative mix of news and analysis. Join us to stay in tune with where TSCA is now and where it is heading.

More on TSCA

Our weekly blog on TSCA and beyond is geared to flag trends and promote thought leadership in environmental law. We hope you will join us and visit The WELL for our current thinking on environmental law and policy.


Erik C. Baptist

Martha E. Marrapese

Charlotte Bertrand
Senior Policy Advisor

More Info

  • This event is complimentary but advance registration is required. Can’t make the date? Register and we’ll send you the slides and recording after the webinar.
  • CLE credit is available for this webinar. Wiley is an accredited or approved CLE provider in the following states: California, New York, Pennsylvania, and Texas. Wiley will apply for credit in the following states: Colorado, Georgia, Idaho, Illinois, Indiana, Kentucky, Mississippi, Oklahoma, Oregon, Rhode Island, Virginia, Vermont, Washington, and Wisconsin. The list of states Wiley is not currently able to offer CLE credit includes: Alabama, Delaware, Indiana, Kansas, Louisiana, Minnesota, Missouri, Nebraska, Nevada, North Carolina, Ohio, South Carolina, Tennessee, Utah, West Virginia, and Wyoming. In these instances, Wiley can offer a certificate of attendance. For those seeking CLE credit, please complete the program evaluation at the end of the program. Wiley will be unable to issue CLE certificates until we have received all required documentation.
  • For New York CLE purposes, this program is appropriate for both newly admitted and experienced attorneys. Note that newly admitted New York attorneys (attorneys admitted two years or less) may earn CLE credit in certain categories of credit through completion of courses in permissible formats, as explained here.
  • Webinar instructions and materials will be distributed prior to the webinar. For more information, please email Rachel Moss at rmoss@wiley.law.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Wiley Rein LLP | Attorney Advertising


Wiley Rein LLP

Wiley Rein LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.